323 related articles for article (PubMed ID: 27980321)
1. Beta Cell Function and Insulin Resistance After Conversion from Tacrolimus Twice-Daily to Extended-Release Tacrolimus Once-Daily in Stable Renal Transplant Recipients.
Ruangkanchanasetr P; Sanohdontree N; Supaporn T; Sathavarodom N; Satirapoj B
Ann Transplant; 2016 Dec; 21():765-774. PubMed ID: 27980321
[TBL] [Abstract][Full Text] [Related]
2. Conversion of stable kidney transplant recipients from a twice-daily prograf to a once-daily tacrolimus formulation: a short-term study on its effects on glucose metabolism.
Uchida J; Kuwabara N; Machida Y; Iwai T; Naganuma T; Kumada N; Nakatani T
Transplant Proc; 2012 Jan; 44(1):128-33. PubMed ID: 22310596
[TBL] [Abstract][Full Text] [Related]
3. Conversion of twice-daily to once-daily tacrolimus is safe in stable adult living donor liver transplant recipients.
Kim SH; Lee SD; Kim YK; Park SJ
Hepatobiliary Pancreat Dis Int; 2015 Aug; 14(4):374-9. PubMed ID: 26256081
[TBL] [Abstract][Full Text] [Related]
4. Effects of conversion from a twice-daily tacrolimus to a once-daily tacrolimus on glucose metabolism in stable kidney transplant recipients.
Uchida J; Iwai T; Kabei K; Machida Y; Kuwabara N; Naganuma T; Kumada N; Nakatani T
Transplant Proc; 2014; 46(2):532-6. PubMed ID: 24656005
[TBL] [Abstract][Full Text] [Related]
5. Trough level from twice daily to once daily tacrolimus in early conversion kidney transplant recipients: a prospective study.
Sukkha S; Chindavijak B; Montakantikul P; Ingsathit A; Nosoongnoen W; Sumethkul V
Int J Clin Pharm; 2017 Dec; 39(6):1298-1303. PubMed ID: 29101615
[TBL] [Abstract][Full Text] [Related]
6. A switch from conventional twice-daily tacrolimus to once-daily extended-release tacrolimus in stable kidney transplant recipients.
Hatakeyama S; Fujita T; Yoneyama T; Yoneyama T; Koie T; Hashimoto Y; Saitoh H; Funyu T; Narumi S; Ohyama C
Transplant Proc; 2012 Jan; 44(1):121-3. PubMed ID: 22310594
[TBL] [Abstract][Full Text] [Related]
7. Conversion to tacrolimus extended-release formulation: short-term clinical results.
Gallego-Valcarce E; Ortega-Cerrato A; Llamas-Fuentes F; Martinez-Fernandez G; Perez-Martinez J; Gomez-Roldan C
Transplant Proc; 2009; 41(6):2326-7. PubMed ID: 19715909
[TBL] [Abstract][Full Text] [Related]
8. Conversion to Once-Daily Tacrolimus Results in Increased p38MAPK Phosphorylation in T Lymphocytes of Kidney Transplant Recipients.
Kannegieter NM; Shuker N; Vafadari R; Weimar W; Hesselink DA; Baan CC
Ther Drug Monit; 2016 Apr; 38(2):280-4. PubMed ID: 26606072
[TBL] [Abstract][Full Text] [Related]
9. Novel Once-Daily Extended-Release Tacrolimus Versus Twice-Daily Tacrolimus in De Novo Kidney Transplant Recipients: Two-Year Results of Phase 3, Double-Blind, Randomized Trial.
Rostaing L; Bunnapradist S; Grinyó JM; Ciechanowski K; Denny JE; Silva HT; Budde K;
Am J Kidney Dis; 2016 Apr; 67(4):648-59. PubMed ID: 26717860
[TBL] [Abstract][Full Text] [Related]
10. No change in insulin sensitivity in renal transplant recipients converted from standard to once-daily prolonged release tacrolimus.
Midtvedt K; Jenssen T; Hartmann A; Vethe NT; Bergan S; Havnes K; Åsberg A
Nephrol Dial Transplant; 2011 Nov; 26(11):3767-72. PubMed ID: 21471328
[TBL] [Abstract][Full Text] [Related]
11. Trough Level and Tacrolimus Variability of Early Converted Once-Daily Tacrolimus: 1-Year Follow-up Study.
Sukkha S; Suansanae T; Iamrahong P; Wiwattanathum P
Transplant Proc; 2020 Apr; 52(3):775-779. PubMed ID: 32143870
[TBL] [Abstract][Full Text] [Related]
12. Long-term follow-up of stable kidney transplant recipients after conversion from tacrolimus twice daily immediate release to tacrolimus once-daily prolonged release: a large single-center experience.
Slatinska J; Rohal T; Wohlfahrtova M; Viklicky O
Transplant Proc; 2013 May; 45(4):1491-6. PubMed ID: 23726604
[TBL] [Abstract][Full Text] [Related]
13. Safety and Efficacy of Once-Daily Prolonged-Release Tacrolimus in Living Donor Liver Transplantation: An Open-Label, Prospective, Single-Arm, Phase 4 Study.
Lee EC; Kim SH; Park SJ
Ann Transplant; 2018 Oct; 23():713-720. PubMed ID: 30310047
[TBL] [Abstract][Full Text] [Related]
14. Long-term Glomerular Filtration Rate and Kidney Disease: Improving Global Outcomes Stage Stability After Conversion to Once-Daily Tacrolimus in Kidney Transplant Recipients.
Tinti F; Umbro I; Poli L; Cappoli A; Garofalo M; Bachetoni A; D'Alessandro MD; Lai S; Berloco PB; Mitterhofer AP
Transplant Proc; 2019; 51(1):147-152. PubMed ID: 30655133
[TBL] [Abstract][Full Text] [Related]
15. The association between trough blood concentration and systemic exposure of tacrolimus: Comparison between once-daily (Advagraf®) and twice-daily (Prograf®) formulation in de novo kidney transplant recipients.
Sukkha S; Chindavijak B; Nosoongnoen W; Phakdeekitchareon B; Kitiyakara C; Sumethkul V
Drug Metab Pharmacokinet; 2020 Feb; 35(1):139-144. PubMed ID: 31727575
[TBL] [Abstract][Full Text] [Related]
16. Effect of conversion from twice-daily to once-daily tacrolimus on glucose intolerance in stable kidney transplant recipients.
Tsuchiya T; Ishida K; Ito S; Deguchi T
Transplant Proc; 2012 Jan; 44(1):118-20. PubMed ID: 22310593
[TBL] [Abstract][Full Text] [Related]
17. Improved kidney graft function after conversion from twice daily tacrolimus to a once daily prolonged-release formulation.
Kolonko A; Chudek J; Wiecek A
Transplant Proc; 2011 Oct; 43(8):2950-3. PubMed ID: 21996198
[TBL] [Abstract][Full Text] [Related]
18. Conversion from twice-daily to once-daily Tacrolimus administration in liver transplant patient: results of long term follow-up.
Giannelli V; Rossi M; Giusto M; Lucidi C; Lattanzi B; Ruffa A; Ginanni Corradini S; Mennini G; Melandro F; Lai Q; Berloco P; Merli M
Eur Rev Med Pharmacol Sci; 2013 Oct; 17(20):2718-20. PubMed ID: 24174352
[TBL] [Abstract][Full Text] [Related]
19. Comparative clinical trial of the variability factors of the exposure indices used for the drug monitoring of two tacrolimus formulations in kidney transplant recipients.
Marquet P; Albano L; Woillard JB; Rostaing L; Kamar N; Sakarovitch C; Gatault P; Buchler M; Charpentier B; Thervet E; Cassuto E
Pharmacol Res; 2018 Mar; 129():84-94. PubMed ID: 29229354
[TBL] [Abstract][Full Text] [Related]
20. Conversion From a Twice-Daily to a Once-Daily Tacrolimus Formulation in Kidney Transplant Recipients.
Kamińska D; Poznański P; Kuriata-Kordek M; Zielińska D; Mazanowska O; Kościelska-Kasprzak K; Krajewska M
Transplant Proc; 2020 Oct; 52(8):2288-2293. PubMed ID: 32247597
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
